CALL FOR PAPERS

CERTIFICATE

IMPACT FACTOR 2018

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

Comparative study of the effects of treatment with herbal product shilanum and high-dose contraceptive pills on functional ovarian cysts

Author: 
Farnaz Sohrabvand, Mohammad Kamalinejad, Mojgan Tansaz, Shima Vazifekhah, Mamak Shariat, Masumeh Masoumi, Maryam Bagheri and Maryam Mohebbi
Subject Area: 
Health Sciences
Abstract: 

Background: Functional ovary cysts (FOC) are among the most common problems in women of reproductive age. Present treatment consists of either high-dose birth control pills or surgery while preserving ovarian tissue. Recent studies have questioned the effectiveness of birth control pills, with some studies even showing them to be ineffectual. The incidences of side effects, therapeutic failure, and unnecessary surgeries for ovarian functional cysts have led us to perform this study comparing the effects of an herbal product of jujube and high-dose birth control pills on FOC regression. Materials and Methods: Sixty women of childbearing age with functional ovarian cysts with diameters of 2-6 cm were randomly divided into two groups that received either high-dose contraceptive pills or Shilanum capsules, a herbal product with an extract of jujube as its active ingredient. Cyst regression was evaluated by transvaginal ultrasound examinations on the second or third day of the second menstrual cycle or after one month and repeated the following month in the case of persisting cysts. Data were analyzed using Chi-square and t-tests as well as other analytical tests where necessary. Results: Sixty patients with a diagnosis of functional ovarian cyst were enrolled. However, at the end of the study, given that some patients failed to refer for further ultrasound evaluation and were inaccessible, data from 26 subjects in the high-dose birth control pill (HD) group and 27 in the Shilanum group were analyzed. Baseline characteristics such as education, professional status, and medication intake were similar. The average age of all participants was 32.61±7.35 years, all of whom were married. Average cyst size before treatment was 27±7mm in the HD group and 39±14mm in the Shilanum group. After treatment, cysts regressed in all patients except for two patients in each group. Conclusion: The Shilanum herbal product with an extract of jujube as its active ingredient was effective on the regression of functional ovarian cysts in more than 90% of cases without any side effects. Since its effect was similar to HD pills, it can be suggested as an alternative to oral contraceptive pills(OCPs) in treating functional ovarian cysts. However, due to the fact that this is the first study with this combination, further studies with larger sample sizes are recommended.

PDF file: 

IJMCE RECOMMENDATION

ONLINE PAYPAL PAYMENT

CURRENT ISSUE

NEWS

CHIEF EDITOR
Rosane Cavalcante Fragoso, Brasil
ASSOCIATE CHIEF EDITOR

   

Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

EDITORIAL BOARD

Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran